DS-1040 tosylate

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

DS-1040 tosylate (DS1040) 是一种活化凝血酶激活纤溶抑制剂 (TAFIa) 的小分子抑制剂，对兔 TAFIa 的 IC50 为 1.7 ng/mL。

DS-1040 tosylate (DS1040)?is a small molecule inhibitor of the activated thrombin-activatable fibrinolysis inhibitor (TAFIa) with IC50 of 1.7 ng/mL for rabbit TAFIa; a novel fibrinolysis-enhancing agent has favorable pharmacokinetic/pharmacodynamic properties and a favorable safety profile.Stroke Phase 2 Clinical.

DS-1040 Tosylate inhibits human carboxypeptidase N (CPN) in vitro with an IC50 of 3.02 mM.

DS-1040 Tosylate (0.0005-0.5 mg/kg; IV) significantly reduces the microthrombi index at doses of 0.005 mg/kg and greater. DS1040 (0.016, 0.031, 0.063, 0.13, 0.25, 0.50 mg/kg; i.v.) increases plasma D-dimer levels in a dose-dependent manner in the microthrombosis model. ED50 and EDmax are 122 and 221 nmol/L, respectively. DS-1040 (0.25, 0.5, 1, 2, 4, 8, 16 mg/kg; orally) also increases plasma D-dimer levels. EC50 and ECmax values are 114 and 231 nmol/L, respectively. Animal Model:Male Slc:Wistar rats Dosage:0.0005, 0.005, 0.05, 0.5 mg/kg Administration:IV Result:Significantly reduced the microthrombi index at doses of 0.005 mg/kg and greater.

DS 1040 | DS1040

Others

Other Targets

Other Targets

Neurological Disease

Stroke

1335138-89-0

465.609

C23H35N3O5S

>98% (HPLC)

In Vitro:?DMSO : 100 mg/mL (214.77 mM)

CC1CCC(CC1)N2C=C(N=C2)CC(CCCN)C(=O)O.CC1=CC=C(C=C1)S(=O)(=O)O

(S)-5-amino-2-((1-((1r,4S)-4-methylcyclohexyl)-1H-imidazol-4-yl)methyl)pentanoic acid compound with 4-methylbenzenesulfonic acid (1:1)

(-20℃)

With Ice Pack

≥ 2 years